Eli Lilly to acquire Akouos for up to about $610 million and develop gene therapies for hearing loss
admin Eli Lilly and Co. LLY, +0.41% said Tuesday it has entered an agreement to acquire…
Read MoreLilly
Lilly gets Fast Track designation for its experimental obesity drug
Eli Lilly and Co. LLY, +0.49% said Thursday that its experimental obesity drug received a…
Read More